June 2, 2002 – Advanced Cell Technology, Inc. (ACT) reported today that nuclear transplantation can be used to generate functional immune-compatible tissues.
June 2, 2002 – Statement by The Ethics Advisory Board of Advanced Cell Technology
May 16,2002 – Letter to Congressman Souder regarding HHS audit of ACT.*
April 16, 2002 – Advanced Cell Technology Announces License of its Cloning Patents to PPL Therapeutics
April 16, 2002 – Advanced Cell Technology Announces License of its Cloning Patents to Immerge Biotherapeutics, INC., a Joint Venture Between Novartis Pharma Ag and Biotransplant, Inc.
February 1, 2002 – ACT Believes It Has Strong Position in Interference Between ACT Patent and Roslin Patent Application
January 31, 2002 – Researchers Develop Primate Stem Cells Without Creating Viable Embryos
November 25, 2001 – Advanced Cell Technology, Inc. (ACT) today announced publication of its research on human somatic cell nuclear transfer and parthenogenesis. The report, published in today’s Journal of Regenerative Medicine, provides the first proof that reprogrammed human cells can supply tissue for transplantation.
November 22, 2001 – Advanced Cell Technology, Inc. (ACT) and its subsidiary Cyagra, Inc. today reported that its proprietary cloning technology has been used to produce healthy and normal adult animals.
October 12, 2001 – Advanced Cell Technology, Inc. (ACT) announced today that it has been awarded a grant from the National Institute of Standards and Technology